Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Open EAY191-S3 ComboMATCH S3 3/6/2023 3%
    Open LUNGMAP LUNGMAP Screening Protocol for NSCLC 1/28/2019
    Open S1501 Carvedilol vs No Trt in Prevention of Cardiac Dysfunction in HER-2+ mBrCa 9/15/2017 38%
    Open S1608 Randomized Ph II for Relapsed Refractory FL 8/10/2017 81%
    Open S1609 DART 1/13/2017 98%
    Open S1703 Disease Monitoring Study 7/16/2018 45%
    Open S1706 Phase II Rando, Double Blind Placebo/Veliparib + RT for Inflammatory Breast 9/12/2018 51%
    Open S1802 PhIII Rando SST v. SST+Surgery or Radiation for Met Prostate Cancer 9/17/2018 62%
    Open S1803 PIII Daratumumab + Lenalidomide Post-Auto SCT Maint for MM 6/27/2019 100%
    Open S1823 miRNA 371 Study in Germ Cell Tumors 6/1/2020 99%
    Open S1827 MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK) 1/10/2020 32%
    Open S1900E LUNGMAP S1900E: KRAS Targeted Therapy Sub-Study 4/2/2021 97%
    Open S1900G Comparing Combinations of Targeted Drugs for Advanced NSCLC that has EGFR and MET Gene Changes 4/3/2023 17%
    Open S1900K Targeted Treatment for Advanced NSCLC that has a MET Exon 14 Skipping Gene Change 12/18/2023 0%
    Open S1904 Decision Support Tool 9/1/2020 96%
    Open S1905 PI/II OBI-3424 for R/R T-ALL/T-LBL 8/17/2020 22%
    Open S1912CD CREDIT 7/26/2021 70%
    Open S1914 A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT versus SBRT Alone in High Risk, Early Stage NSCLC 3/25/2020 73%
    Open S1918 Ph II/III study of R-miniCHOP +/- oral aza in elderly with newly diganosed DLBCL 3/19/2021 23%
    Open S1922 Randomized Phase II Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma 12/16/2019 34%
    Scroll Table